Intech Biopharm Ltd (6461) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.125x

Based on the latest financial reports, Intech Biopharm Ltd (6461) has a cash flow conversion efficiency ratio of -0.125x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-123.21 Million ≈ $-3.88 Million USD) by net assets (NT$987.98 Million ≈ $31.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Intech Biopharm Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Intech Biopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 6461 current and long-term liabilities for a breakdown of total debt and financial obligations.

Intech Biopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intech Biopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Munsin Garment TWO:2916	-0.053x
Insumos Agroquimicos SA BA:INAG	-1.082x
Korea Flange KO:010100	0.060x
Fullerton Technology Co Ltd TW:6136	0.035x
Y-Entec Co. Ltd KQ:067900	0.018x
Hainan Airlines Co Ltd B SHG:900945	1.672x
Raisio Oyj HE:RAIKV	0.029x
Cytogen Inc KQ:217330	-0.059x

Annual Cash Flow Conversion Efficiency for Intech Biopharm Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Intech Biopharm Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 6461 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$814.28 Million ≈ $25.65 Million	NT$-269.22 Million ≈ $-8.48 Million	-0.331x	-89.15%
2023-12-31	NT$1.17 Billion ≈ $36.79 Million	NT$-204.13 Million ≈ $-6.43 Million	-0.175x	+5.28%
2022-12-31	NT$1.03 Billion ≈ $32.50 Million	NT$-190.39 Million ≈ $-6.00 Million	-0.185x	-23.05%
2021-12-31	NT$1.34 Billion ≈ $42.14 Million	NT$-200.61 Million ≈ $-6.32 Million	-0.150x	-19.06%
2020-12-31	NT$1.33 Billion ≈ $41.86 Million	NT$-167.38 Million ≈ $-5.27 Million	-0.126x	-4.52%
2019-12-31	NT$1.57 Billion ≈ $49.43 Million	NT$-189.09 Million ≈ $-5.96 Million	-0.121x	+22.84%
2018-12-31	NT$1.49 Billion ≈ $46.88 Million	NT$-232.43 Million ≈ $-7.32 Million	-0.156x	-45.69%
2017-12-31	NT$1.36 Billion ≈ $42.70 Million	NT$-145.29 Million ≈ $-4.58 Million	-0.107x	--

About Intech Biopharm Ltd

TWO:6461 Taiwan Biotechnology

Market Cap

$92.41 Million

NT$2.93 Billion TWD

Market Cap Rank

#19482 Global

#1118 in Taiwan

Share Price

NT$17.90

Change (1 day)

-0.56%

52-Week Range

NT$14.40 - NT$25.05

All Time High

NT$57.64